Celldex Therapeutics Inc (CLDX)
2.77
+0.11 +4.14%
NASDAQ
Jun 2, 20:00
Delayed 2m
USD
View All Key Stats
Key Stats
| Income Statement | |
| Revenue (TTM) | 4.876M |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (TTM) | -2.96 |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Net Income (TTM) | -46.26M |
| Profitability | |
| Gross Profit Margin (Quarterly) | -- |
| Profit Margin (Quarterly) | -462.8% |
| Dividend | |
| Dividend Yield (Forward) | Upgrade |
| Dividend Yield | 0.00% |
| Price and Valuation | |
| Market Cap | 52.46M |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| PS Ratio | 8.962 |
| PE Ratio | -- |
| Price to Book Value | 0.6267 |
| Other | |
| Beta (5Y) | Upgrade |
| Debt to Equity Ratio | 0.00 |
| Free Cash Flow (Quarterly) | -12.34M |
| Return on Equity | Upgrade |
View All CLDX News
News
-
WireHeadlineTime (ET)
-
Yahoo05/28 15:22
-
Yahoo05/25 11:30
-
Globe Newswire05/06 16:01
-
Yahoo05/06 11:30
-
Globe Newswire05/06 08:01
-
Yahoo04/24 08:56
-
SA Breaking News04/22 09:19
-
Yahoo04/14 08:37
-
Yahoo04/06 08:53
-
MT Newswires03/26 16:29
View All Events
Events
| Date | Type | Description |
|---|---|---|
| 08/07/2020 16:30 EDT | Misc | Celldex Therapeutics Inc Second Quarter Earnings Conference Call in 2020 |
| 08/07/2020 | Earnings | Celldex Therapeutics Inc Second Quarter Earnings in 2020 Release |
| 06/18/2020 09:00 EDT | Misc | Celldex Therapeutics Inc Annual General Meeting for 2019 |
| 05/06/2020 | Earnings | Celldex Therapeutics Inc First Quarter Earnings Results for 2020 |
| 03/26/2020 | Earnings | Celldex Therapeutics Inc Fourth Quarter Earnings Results for 2019 |
| 03/26/2020 | Misc | Celldex Therapeutics Inc Annual Report for 2019 |
| 11/12/2019 | Earnings | Celldex Therapeutics Inc Third Quarter Earnings Results for 2019 |
| 08/07/2019 16:30 EDT | Misc | Celldex Therapeutics Inc Second Quarter Earnings Conference Call in 2019 |
| 08/07/2019 | Earnings | Celldex Therapeutics Inc Second Quarter Earnings in 2019 Release |
| 06/19/2019 09:00 EDT | Misc | Celldex Therapeutics Inc Annual General Meeting in 2018 |
Fundamentals
Income Statement View Statement
Ratings & Reports
- Y-Rating Upgrade
- Value Score Upgrade
- Fundamental Score Upgrade
- Valuation (Hist. Mult.) Upgrade
- Y-Rating Report Download
- One Page Report Download
Advertisement
Edit
Profile
- URL: http://www.celldex.com
- Investor Relations URL: http://ir.celldex.com/index.cfm
- HQ State/Province: New Jersey
- Sector: Healthcare
- Industry: Biotechnology
- Equity Style: Small Cap/Value
- Next Earnings Release: Aug. 07, 2020
- Last Earnings Release: May. 06, 2020
- Next Ex-Dividend Date: N/A
- Last Ex-Dividend Date: N/A
- Description: Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. Its pipeline products are Varlilumab, CDX-301, CDX-1140, and CDX-3379.
Analyst Coverage
| Consensus Recommendations | |
| Buy Recommendations | Upgrade |
| Outperform Recommendations | Upgrade |
| Hold Recommendations | Upgrade |
| Underperform Recommendations | Upgrade |
| Sell Recommendations | Upgrade |
| Consensus Recommendation | Upgrade |
| Consensus Rating | Upgrade |
| Target Price | |
| Price | 2.77 |
| Price Target | Upgrade |
| Price Target Upside (Daily) | Upgrade |
Top Fund Holders
| Symbol | Name | Weighting |
|---|---|---|
| KRXCX | Kinetics Medical Adv C | 0.02% |
Other Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership Nasdaq
- SEC Filings SEC
- CLDX Tweets Stocktwits
Advertisement
